Develops a biotechnology platform that replicates low-input genomic samples while preserving methylation markers to enhance early disease detection.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Epinoma is an early-stage biotechnology company developing a novel method to quantify epigenetic signals for early-stage cancer detection and minimal residual disease (MRD) monitoring. Early backers of the company include renowned Harvard geneticist Dr. George Church, and the company has also built a strong research collaboration with researchers at TU Dortmund in Germany.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Epinoma Management Team
Epinoma Valuations & Financials
View real-time NPM data on Epinoma stock including daily Epinoma stock price estimates, valuation history, and historical share price information. Access Epinoma financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Epinoma pricing across six independent market signals. Looking for private company due diligence data sources on Epinoma? Get in touch to learn more.
Similar Companies
like Epinoma
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
BackOps.ai
Commerce & Marketplaces
Handles routine operational tasks using AI hooked into supply‑chain systems to boost efficiency and reduce manual work.
ClipLine
Provides integrated software solutions to streamline operations and improve communication across multi-location businesses.
Rainmaker
AI & Machine Learning
Provides cloud-based sales and revenue management tools for lead generation, sales automation, and analytics to boost business growth.
Lunewave
Develops advanced antenna and sensor technology for high-resolution, long-range detection in automotive, telecom, aerospace, and defense.
Alaffia Health
Healthcare & Life Sciences
Automates claim review with AI agents which align records, policies, and clinical judgment.
Kos
Manufactures organic, plant-based protein powders and functional superfood supplements engineered from traceable, non-GMO ingredients.
David Evans and Associates
Industrials
Designs that optimize industrial control systems and equipment tailored to heavy-duty operational needs.
Vesttoo
Provide insurers that transfer risk and raise capacity through capital market tools, and grant investors access to diversified, uncorrelated insurance-linked assets.
FAQ
We have answers
Epinoma stock does not trade on public stock exchanges. Epinoma stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Epinoma stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Epinoma Stock does not trade on public stock exchanges. In order to sell Epinoma shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Epinoma does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Epinoma share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Epinoma stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Epinoma stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Epinoma stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Epinoma is a private company and has not had an IPO. There is currently no Epinoma IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Epinoma IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
